Ileal neuroendocrine tumor
Learn about Ileal neuroendocrine tumor, its reported features, relevant specialists, and questions to discuss at a medical consultation.
Also known as: Ileal neuroendocrine neoplasm
The sources compiled here do not cover: treatment, prevention, prognosis, prevalence. Ask the treating doctor about these.
What it is
From: Orphanet
Ileal neuroendocrine tumor is a rare, primary, malignant, epithelial neoplasm of the small intestine arising from enterochromaffin cells in the ileum (usually the terminal ileum). Clinical behavior depends on the histologic grade, but initially it is generally characterized by vague abdominal symptoms (cramping, bloating, diarrhea) with insidious onset, although sometimes it could present with signs of bowel obstruction/perforation or gastrointestinal bleeding. Diagnosis in advanced stages with regional or distant spread is common, but signs of carcinoid syndrome (flushing, sweating, diarrhea) are usually not apparent until hepatic metastasis has occurred.
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Episodic abdominal pain · Very frequent (99-80%)
- An intermittent form of abdominal pain.
- Increased serum serotonin · Very frequent (99-80%)
- A increased concentration of serotonin in the blood.
- Intermittent diarrhea · Very frequent (99-80%)
- Repeated episodes of diarrhea separated by periods without diarrhea.
- Dermatological manifestations of systemic disorders · Very frequent (99-80%)
- Small intestine carcinoid · Obligate (100%)
- Abnormal bowel sounds · Frequent (79-30%)
- An anomaly of the amount or nature of abdominal sounds. Abdominal sounds (bowel sounds) are made by the movement of the intestines as they promote passage of abdominal contents by peristalsis.
- Arterial occlusion · Frequent (79-30%)
- Blockage of blood flow through an artery.
- Chronic fatigue · Frequent (79-30%)
- Subjective feeling of tiredness characterized by a lack of energy and motivation that persists for six months or longer.
- Elevated circulating hepatic transaminase concentration · Frequent (79-30%)
- Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage.
- Episodic vomiting · Frequent (79-30%)
- Paroxysmal, recurrent episodes of vomiting.
- Extrahepatic cholestasis · Frequent (79-30%)
- Impairment of bile flow due to obstruction in large bile ducts outside the liver.
- Lymphadenopathy · Frequent (79-30%)
- Enlargement (swelling) of a lymph node.
- Nausea · Frequent (79-30%)
- A sensation of unease in the stomach together with an urge to vomit.
- Weight loss · Frequent (79-30%)
- Reduction of total body weight.
Other findings in the same source
From: Orphanet
Additional reported features include Elevated serum acid phosphatase (Frequent (79-30%)); Functional intestinal obstruction (Frequent (79-30%)); Gastrointestinal obstruction (Frequent (79-30%)); Iron deficiency anemia (Frequent (79-30%)); Intestinal fistula (Occasional (29-5%)); Abnormal bronchus morphology (Very rare (<4-1%)); Arrhythmia (Very rare (<4-1%)); Cardiogenic shock (Very rare (<4-1%)); Edema (Very rare (<4-1%)); Hydronephrosis (Very rare (<4-1%)). This is a selected summary, not a complete description of the condition.
When it may begin
From: Orphanet
Adult
Inheritance in the source
From: Orphanet
Not applicable
Which doctor should you see?
The suggested department for discussing Ileal neuroendocrine tumor is Oncology, with a oncologist and relevant organ specialist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.
Additional services that may be relevant, depending on the findings, include: Relevant organ specialist / Surgical Oncology as indicated.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- Has the exact tumour type been confirmed, and is staging relevant?
- What is the goal of each proposed treatment option?
- How will side effects, daily function and supportive care be addressed?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for Ileal neuroendocrine tumor. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
Oncology is not listed separately on The Doctor Index; the nearest speciality is medical oncology. Every profile shows the doctor’s registration and what has been checked.
Sources
- Orphanet — Ileal neuroendocrine tumor — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-1247.